PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1698393
PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1698393
The global pharmaceutical filtration market is projected to grow at a CAGR of 8.50% to be worth US$21.24 billion in 2030 from US$14.64 billion in 2025.
Growing demand for protein-based drugs because of the rising prevalence of inflammatory, infectious, and cardiovascular diseases across the globe is expected to drive the pharmaceutical filtration market growth during the forecast period. Moreover, increasing emphasis on biologics for the development of treatment of various diseases is a major factor contributing to the overall market growth.
A key factor supporting the growth of the pharmaceutical filtration market is the rising incidence of chronic conditions such as diabetes, asthma, cancer, and autoimmune diseases. The growing number of chronic disease cases has led to a higher demand for advanced therapeutic drugs worldwide. According to the World Health Organization, cancer is one of the leading causes of death globally, accounting for nearly 10 million deaths in 2020.
Another significant driver of the pharmaceutical filtration market is the rising investment in the research and development of biologics. The adoption of innovative treatment therapies, such as monoclonal antibodies, recombinant DNA (R-DNA) technology, therapeutic proteins, and vaccines, has spurred growth in biotechnology and pharmaceutical companies. These companies rely on filtration techniques, including membranes, capsules, and cartridges, to support their operations.
Geographically, the pharmaceutical filtration market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East & Africa. North America is anticipated to lead the market, driven by the growing biopharmaceutical industry and advancements in manufacturing facilities. Meanwhile, the Asia Pacific region is projected to be the fastest-growing market, fueled by a large patient population with chronic diseases and increasing vaccine production in countries like China and India. These factors are significantly contributing to the expansion of the global pharmaceutical filtration market.
Some of the major players covered in this report include 3M, Danaher Corporation, GE Healthcare, GEA Group, Graver Technologies, Merck Millipore, Parker Hannifin Corporation, Repligen Corporation, Sartorius Stedim Biotech, Thermo Fisher Scientific among others.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
The study also analyzed the pharmaceutical filtration market into the following regions, with country-level forecasts and analysis as below: